Skip to main content
In stock|Targeted Therapy (Investigational)

Guadecitabine

Oncology TypeHematologic (MDS/AML)
Drug Class / MechanismHypomethylating / Investigational Agent
No Image
Description

Guadecitabine is classified as a Hypomethylating / Investigational Agent, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy (Investigational)
Oncology TypeHematologic (MDS/AML)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3